Opioid Use Disorder News, Research & Studies

Medicine

Opioid Use Disorder

Opioid Use Disorder news, research, studies, and rapid health briefings. Visit Viral Vitalism for plain-language context, evidence boundaries, and related signals.

1 published articleBuilding this topic

MedicineEarly evidenceGLP-1

GLP-1s, Dopamine, and Addiction: The Substance Use Signal

GLP-1 medications may do more than reduce appetite for food. Early clinical trials, real-world data, and preclinical research suggest they may also affect craving, reward, alcohol intake, and substance-use patterns - but the science is still developing.

VV Signal Score

Early or context-dependent

Sources: 19
Studies: 8
Claims: 3

BMJ Veterans SUD CohortExenatide AUDGLP-1 Addiction Neurobiology Review

16 min readRead->

Research map

View related studies

Research records connected to this topic through topic tags, source records, and timeline events.

Tier 3Observational study

Semaglutide OUD Overdose

Semaglutide and opioid overdose risk in patients with type 2 diabetes and opioid use disorder

Observational study from 2024 in JAMA Network Open, translated into key findings, limitations, and consumer relevance.

JAMA Network Open / 2024->

Useful source library entries

Semaglutide and opioid overdose risk in patients with type 2 diabetes and opioid use disorder GLP-1R Agonist Treatment for Opioid Use Disorder Effects of semaglutide and tirzepatide on stimulant and opioid use disorder outcomes in real-world populations SAMHSA National Helpline